UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

For the quarterly period ended October 30, 201029, 2011

OR

For the transition period from                    to

Commission file number 0-13200

Astro-Med, Inc.

(Exact name of registrant as specified in its charter)

(401) 828-4000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨x    No  ¨.

Indicate by check mark whether the registrant is a large accelerated filer or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes  ¨    No  x.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of                  the latest practicable date.

Common Stock, $.05 Par Value – 7,229,7957,396,728 shares

(excluding treasury shares) as of December 3, 2010November 30, 2011

ASTRO-MED, INC.

ASTRO-MED, INC.INDEX

INDEX

-2-

Part I. FINANCIAL INFORMATION

ASTRO-MED, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

See Notes to condensed consolidated financial statements (unaudited).

-3-

ASTRO-MED, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

See Notes to condensed consolidated financial statements (unaudited).

-4-

ASTRO-MED, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

See Notes to condensed consolidated financial statements (unaudited).

-5-

ASTRO-MED, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

(1) Overview

Headquartered in West Warwick, Rhode Island, Astro-Med Inc. develops and manufactures a broad range of specialty printers and data acquisition systems. The Company’sOur products are distributed through itsour own sales force and authorized dealers in the United States. We also sell to customers outside of the United States Canada, and Western Europe andprimarily by using authorized dealers elsewhere in the world.and international sales representatives, who are managed from our foreign sales offices. Astro-Med, Inc. products are sold under the brand names Astro-Med^® Test & Measurement, Grass^® Technologies and QuickLabel^® Systems and are employed around the world in a wide range of aerospace, automotive, communications, chemical, food and beverage, medical, military, industrial, and packaging applications.

Unless otherwise indicated, references to “Astro-Med,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to Astro-Med, Inc. and its consolidated subsidiaries.

(2) Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared by Astro-Med pursuant to the rules and regulations of the Securities and Exchange Commission, and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2010.2011.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Some of the more significant estimates relate to the allowances for doubtful accounts and credits, inventory valuation, impairment of long-lived assets and goodwill, income taxes, share-based compensation and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, past historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates.

Subsequent eventsCertain amounts in prior year’s financial statements have been evaluated by management throughreclassified to conform to the filing of this form 10-Q with the SEC.current year’s presentation.

(3) Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

(4) Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares for stock options outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:

For the three and nine months ended October 29, 2011, the diluted per share amounts do not reflect options outstanding of 679,890 and 664,690, respectively. For the three and nine months ended October 30, 2010, the diluted per share amounts do not reflect options outstanding of 782,346. For the three and nine months ended October 31, 2009, the diluted per share amounts do not reflect options outstanding of 794,727 and 800,686, respectively. These outstanding options were not included, due to their anti-dilutive effect, as the exercise price of the options was greater than the average market price of the underlying stock during the periods presented.

-6-

(5) Revenue Recognition

The majority of Astro-Med’s product sales are recorded at the time of shipment, when legal title has transferred and risk of loss passes to the customer, when persuasive evidence of an arrangement exists, the seller’s price to the buyer is fixed or determinable and collectibility is reasonably assured in accordance with the requirements in Staff Accounting Bulletin (“SAB”) 104, “Revenue Recognition in Financial Statements.” When a sale arrangement involves training or installation, the deliverables in the arrangement are evaluated to determine whether they represent separate units of accounting in accordance with SAB 104 and FASB’s Accounting Standards Codification (ASC) 605-25, “Revenue Recognition-Multiple-Element Arrangements.” This evaluation occurs at inception of the arrangement and as each item in the arrangement is delivered. The total fee from the arrangement is allocated to each unit of accounting based on its relative fair value. Fair value for each element is established generally based on the sales price charged when the same or similar element is sold separately. Revenue is recognized when revenue recognition criteria for each unit of accounting are met. When other significant obligations remain after products are delivered, revenue is recognized only after such obligations are fulfilled. All of our equipment contains embedded operating systems and data management software which is included in the purchase price of the equipment. The software is deemed incidental to the systems as a whole, as it is not sold or marketed separately and its production costs are minor as compared to those of the hardware system. Returns and customer credits are infrequent and are recorded as a reduction to sales. Rights of return are not included in sales arrangements. Revenue associated with products that contain specific customer acceptance criteria is not recognized before the customer acceptance criteria are satisfied. Discounts from list prices are recorded as a reduction to sales. Amounts billed to customers for shipping and handling fees are included in sales while related shipping and handling costs are included in cost of sales.

Infrequently, Astro-Med recognizes revenue for non-recurring engineering (NRE) fees for product modification orders upon completion of agreed-upon milestones. Revenue is deferred for any amounts received prior to completion of milestones. Certain of our NRE arrangements include formal customer acceptance provisions. In such cases, we determine whether we have obtained customer acceptance for the specific milestone before recognizing revenue. NRE fees have not been significant in the periods presented herein.

Infrequently, Astro-Med receives requests from customers to hold product being purchased from us for the customers’ convenience. Revenue is recognized for such bill and hold arrangements in accordance with the requirements of SAB 104 which requires, among other things, the existence of a valid business purpose for the arrangement; the transfer of ownership of the purchased product; a fixed delivery date that is reasonable and consistent with the buyer’s business purpose; the readiness of the product for shipment; the use of customary payment terms; no continuing performance obligation by us; and segregation of the product from our inventories. Bill and hold arrangements have not been significant in the periods presented herein.

(6) Share-Based Compensation

Astro-Med has one equity incentive plan (the “Plan”) under which incentive stock options, non-qualified stock options, restricted stock and other equity based awards may be granted to directors, officers and certain employees. To date, only options have been granted under the Plan. Options granted to employees vest over four years. An aggregate of 1,000,000 shares were authorized for awards under the Plan. The exercise price of each stock option will be established at the discretion of the Compensation Committee; however, any incentive stock options granted must be at an exercise price of not less than fair market value at the date of grant. The Plan provides for an automatic annual grant of ten-year options to purchase 5,000 shares of stock to each non-employee director upon the adjournment of each annual shareholders’ meeting. Each such option is exercisable at the fair market value as of the grant date and vests immediately prior to the next succeeding annual shareholders’ meeting. During the third quarter of fiscal 2012, 5,000 options were granted to Mitchell Quain in connection with his election as a member of Astro-Med’s Board of Directors. At October 30, 2010, 726,50029, 2011, 683,444 shares were available for grant under the Plan.

We have estimated the fair value of each option on the date of grant using the Black-Scholes option-pricing model. Our estimate of share-based compensation requires a number of complex and subjective assumptions including our stock price volatility, employee exercise patterns (expected life of the options), the risk-free interest rate and the Company’s dividend yield. The stock price volatility assumption is based on the historical weekly price data of our common stock over a period equivalent to the weighted average expected life of our options. Management evaluated whether there were factors during that period which were unusual and would distort the volatility figure if used to estimate future volatility and concluded that there were no such factors. In determining the expected life of the option grants, the Company has observed the actual terms of prior grants with similar characteristics and the actual vesting schedule of the grant and has assessed the expected risk tolerance of different option groups. The risk-free interest rate is based on the actual U.S. Treasury zero coupon rates for bonds matching the expected term of the option as of the option grant date.

-7-

The fair value of stock options granted during the nine months ended October 30, 201029, 2011 and October 31, 200930, 2010 was estimated using the following assumptions:

The weighted average fair value per share for options granted was $2.12$2.03, $2.05, and $1.86 during the first, quartersecond, and third quarters of fiscal 20112012, respectively. On a comparative basis, the weighted average fair value per share for options granted was $2.12 and $2.06 during the second quarter of fiscal 2011 compared to $2.40 and $2.28 during the first and second quarters of fiscal 2010.2011. No options were granted during the third quarter of fiscal 2011 and 2010.2011.

Aggregated information regarding stock options granted under the Plan for the nine months ended October 30, 201029, 2011 is summarized below:

Share-based compensation expense was recognized as follows:

As of October 30, 201029, 2011 there was $370,929$227,744 of unrecognized compensation expense related to unvested options.

Astro-Med has an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the date of purchase. A total of 247,500 shares were reserved for issuance under this plan. During the quarters ended October 29, 2011 and October 30, 2010, 1,210 and October 31, 2009, 1,993 and 2,331 shares respectively, were purchased under this plan. During the nine months ended October 29, 2011 and October 30, 2010, 4,487 and October 31, 2009, 5,660 and 7,416 shares respectively, were purchased under this plan. As of October 30, 2010, 78,85829, 2011, 72,521 shares remain available.

-8-

(7)(6) Comprehensive Income

The Company’s comprehensive income is as follows:

(8)(7) Inventories

Inventories are stated at the lower of cost (first-in, first-out) or market and include material, labor and manufacturing overhead. The components of inventories are as follows:

(9)(8) Income Taxes

The Company’s effective tax rates for the periods, which are based on the projected effective tax rate for the full year, are as follows:

During the third quarter of fiscal 2012, we recognized an income tax expense of approximately $319,000 which included an expense of $432,000 on the quarter’s pre-tax income and a benefit of $113,000 related to the difference between the prior year’s tax provision and the actual returns as filed. During the third quarter of fiscal 2011, we recognized an income tax benefit of approximately $61,000, which included an expense of $340,000 on the quarter’s pre-tax income, a benefit of $251,000 related to the favorable resolution of a previously uncertain tax position and a benefit of $150,000 related to the difference between the prior year’s tax provision and the actual returns as filed.

During the third quarter of fiscal 2010,nine months ended October 29, 2011, we recognized an income tax expense of approximately $353,000,$1,070,000, which included an expense of $378,000$1,183,000 on the quarter’snine month’s pre-tax income and a benefit of $25,000$113,000 related to the difference between the prior year’s tax provision and the actual returnreturns as filed.

During the nine months ended October 30, 2010, we recognized an income tax expense of approximately $462,000, which included an expense of $863,000 on the nine month’s pre-tax income, a benefit of $251,000 related to the favorable resolution of a previously uncertain tax position and a benefit of $150,000 related the difference between the prior year’s tax provision and the actual returns as filed. During the nine months ended October 31, 2009, we recognized an income tax expense of approximately $544,000, which included an expense of $569,000 on the nine month’s pre-tax income and a benefit of $25,000 related to the difference between the prior year’s tax provision and the actual return as filed.

As of October 30, 2010,29, 2011, the Company’s cumulative unrecognized tax benefits totaled $667,469$758,200 compared to $875,225$726,661 as of January 31, 2010. During the third quarter of the current year, we recognized $251,000 of a previously unrecognized tax benefit as a result of the expiration of statutes of limitations. We continue to accrue interest and penalties to2011. There were no developments affecting unrecognized tax benefits induring the income tax provision.

-9-

(10)(9) Segment Information

The Company reports three segments consistent with its sales product groups: Test & Measurement (T&M); QuickLabel Systems (QuickLabel) and Grass Technologies (Grass). The Company evaluates segment performance based on the segment profit before corporate expenses.

Summarized below are the Net Sales and Segment Operating Profit for each reporting segment:

(11)(10) Recent Accounting Pronouncements

Goodwill

In September 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) 2011-08, “Intangibles—Goodwill and Other (Topic 350): Testing Goodwill for Impairment” which is intended to reduce the complexity and costs related to the testing goodwill for impairment. ASU 2011-08 allows an entity the option to make a qualitative evaluation about the likelihood of goodwill impairment in order to determine whether it is necessary to perform the two-step quantitative goodwill impairment test already included in Topic 350. An entity will no longer be required to calculate the fair value of a reporting unit unless the entity determines, based on its qualitative assessment, that it is more likely than not that the fair value of the reporting unit is less than its carrying amount. ASU 2011-08 also expands upon the examples of events and circumstances that an entity should consider between annual impairment tests in determining whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. This amended guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted. We do not expect the adoption of ASU 2011-08 to have a material effect on our consolidated financial position or results of operations.

Comprehensive Income

In June 2011, the FASB issued ASU 2011-05, “Presentation of Comprehensive Income,” which requires entities to present the components of net income and other comprehensive income either as one continuous statement or as two consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of changes in shareholders’ equity. While ASU-2011-05 changes the presentation of comprehensive income, it does not change the components that are recognized in net income or comprehensive income under current accounting guidance. This amended guidance is effective for fiscal years, and interim periods within those years, ending December 15, 2011, and must be applied retroactively. Since ASU 2011-05 impacts presentation only, the adoption of this guidance will not have any effect on our consolidated financial position or results of operations.

Fair Value Measurements

In May 2011, the FASB issued ASU 2011-04, “Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs,” which is intended to improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with U.S. GAAP and IFRS. ASU 2011-04 does not extend the use of fair value accounting, but provides guidance on how it should be applied where its use is already required or permitted by other standards within U.S. GAAP or IFRSs. ASU 2011-04 changes the wording used to describe many requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements. Additionally, ASU 2011-04 clarifies the FASB’s intent about the application of existing fair value measurement. This update is effective for interim and annual periods beginning after December 15, 2011. We do not expect the provisions of ASU 2011-04 to have a material effect on our consolidated financial position or results of operations.

In January 2010, the FASB issued Accounting Standards Update (ASU)ASU 2010-06, “Improving Disclosures About Fair Value Measurement,” which requires reporting entities to make new disclosures about recurring or nonrecurring fair value measurements including significant transfers into and out of Level 1 and Level 2 fair value measurements and information on purchases, sales, issuances and settlements on a gross basis in the reconciliation of Level 3 fair value measurements. ASU 2010-06 is effective for annual periods beginning after December 15, 2009, except for Level 3 reconciliation disclosures which arewere effective for annual periods beginning after December 15, 2010. The adoption of ASU 2010-06 did not have a material impacteffect on our consolidated financial position or results of operations.

Revenue Recognition

In October 2009, the FASB issued ASU 2009-13, “Revenue Recognition (Topic 605)—Multiple-Deliverable Revenue Arrangements—a consensus of the FASB Emerging Issues Task Force” and ASU 2009-14, “Software (Topic 985)—Certain Arrangements That Include Software Elements—a consensus of the FASB Emerging Issues Task Force.” ASU 2009-13 provides amendments to the criteria in Subtopic 605-25 for separating consideration in multiple-deliverable arrangements.

The amendments in this update established a selling price hierarchy for determining the selling price of a deliverable. ASU 2009-13 also eliminates the residual method of allocating arrangement consideration.consideration and significantly expands the disclosures required for multiple-element revenue arrangements. ASU 2009-14 removes (1) tangible products containing software components and (2) non-software components that function together to deliver the tangible products essential functionality from the scope of software revenue guidance (ASC 965-605). ASU 2009-14 also provides guidance on determining whether software deliverables in an arrangement that includes a tangible product are covered by the scope of the software revenue guidance. We adopted ASU 2009-13 and ASU 2009-14 should be applied on a prospective basisprospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010, with early adoption permitted. We are currently evaluatingFebruary 1, 2011. Adoption of the impact of adopting these updatesnew guidance did not have a material effect on our consolidated financial position and results of operations.

Other Accounting Changes

In May 2009, the FASB issued guidance included in ASC 855, “Subsequent Events,” which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the financial statements are issued. In particular, the guidance addresses: the period after the balance sheet date during which management of a reporting entity shall evaluate events or transactions that may occur for potential recognition or disclosure in the financial statements; the circumstances under which an entity shall recognize events or transactions occurring after the balance sheet date in its financial statements; and the disclosures that an entity shall make about events or transactions that occurred after the balance sheet date. This guidance became effective for interim and annual reporting periods ending after June 15, 2009. The adoption did not have a material impact on our consolidated financial position or results of operations.

-10-

Except for the ASU’s discussed above, all other ASUs issued by the FASB as of the filing date of this Quarterly Report on Form 10-Q are not expected to have a material effect on our consolidated financial statements.

(12)(11) Securities Available for Sale

Pursuant to our investment policy, securities available for sale include state and municipal securities with various contractual or anticipated maturity dates ranging from twoone to twentytwenty-six months. During the second quarter of this year, our remaining auction rate security was settled by our investment advisor at par value. Securities available for sale are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) in shareholders’ equity until realized. Realized gains and losses from the sale of available for sale securities, if any, are determined on a specific identification basis. A decline in the fair value of any available for sale security below cost that is determined to be other than temporary will result in a write-down of its carrying amount to fair value. No such impairment charges were recorded for any period presented. All short-term investment securities have original maturities greater than 90 days at the time of purchase.days. The fair value, amortized cost and gross unrealized gains and losses of the securities are as follows:

(13)(12) Fair Value

We measure our financial assets at fair value on a recurring basis in accordance with the guidance provided in ASC 820, “Fair Value Measurement and Disclosures” which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In addition, ASC 820 establishes a three-tiered hierarchy for inputs used in management’s determination of fair value of financial instruments that emphasizes the use of observable inputs over the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect management’s belief about the assumptions market participants would use in pricing a financial instrument based on the best information available in the circumstances.

The fair value hierarchy is summarized as follows:

The following table represents the fair value hierarchy for our financial assets (cash equivalents and investments) measured at fair value on a recurring basis:

-11-

At January 31, 2010, the Level 3 asset consisted of an auction rate security whose underlying assets were backed by municipal assets. While we were continuing to earn interest at the maximum contractual rate, this investment was not trading and therefore did not have a readily determinable market value. The Company used the services of a global investment management and advisory firm to manage its auction rate security position. This investment management firm had developed and implemented a proprietary methodology for pricing auction rate securities using a disciplined discounted cash flow approach to establish fair market valuation.(14) Life Insurance Proceeds

During the second quarter of fiscal 2012, we recognized income on key-man life insurance proceeds of $300,000. This income is included in other income in the current year, the remaining auction rate security held by the Company was redeemed by our investment advisor at par value. Accordingly, we recorded an unrealized gainaccompanying consolidated statement of $11,330 related to the settlement of the remaining auction rate security as of October 30, 2010.

The following table provides a summary of changes in fair value of our auction rate securitiesoperations for the nine monthsmonth period ended October 30, 2010:29, 2011.

(14)(15) Litigation Settlement

In November 2009, Astro-Med was awarded a $1,391,000 judgment related to a lawsuit filed by the Company against a former employee and a competitor business. At issue in the lawsuit was the violation of a non-competition agreement which the former employee had signed as a condition of employment with Astro-Med. The $1,391,000 judgment included both punitive and exemplary damages, as well as attorney fees (all of which have been previously expensed) and related interest earned on the judgment and was recorded as a gain on legal settlement in the consolidated statement of operations and as a receivable in prepaid and other current assets in the consolidated balance sheet for the fiscal year ended January 31, 2010. In November 2009, the Company also filed a motion to amend the original judgment to include additional legal fees of $73,000. This motion was granted on February 12, 2010. On February 17, 2010, the Company collected a total of $1,495,000 related to this legal proceeding, which included the $1,391,000 gain on legal settlement recorded in the fourth quarter of fiscal 2010 and $104,000 for interest and the additional attorney fees as granted pursuant to the February 12, 2010 motion. The $104,000 was recorded as an additional gain on legal settlement in the first quarter of fiscal 2011 and is included in other income in the accompanying consolidated statement of operations for the nine month period ended October 30, 2010.

-12-

Item 2.

ASTRO-MED, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

Business Overview

This section should be read in conjunction with Astro-Med’s Condensed Consolidated Financial Statements included elsewhere herein and our Annual Report on Form 10-K for the fiscal year ended January 31, 2010.2011.

Astro-Med is a multi-national enterprise, which designs, develops, manufactures, distributes and services a broad range of products that acquire, store, analyze and present data in multiple formats. The Company organizes its structure around a core set of competencies, including research and development, manufacturing, service, marketing and distribution. We market and sell our products and services through the following three sales product groups:

Astro-Med markets and sells its products and services globally through a diverse distribution structure of sales personnel, manufacturing representatives and dealers that deliver a full complement of branded products and services to customers in our respective markets.

-13-

Results of Operations

Three Months Ended October 30, 201029, 2011 vs. Three Months Ended October 31, 200930, 2010

Net sales by product group and current quarter percentage change over prior year for the three months ended October 30, 201029, 2011 and October 31, 2009,30, 2010 were:

The Company’s current year third quarter sales were $18,329,000, representing$19,569,000, a 10.0% increase as compared to the previous6.8% improvement over prior year’s third quarter sales of $16,658,000 and a 3.2% improvement over current year second quarter sales of $17,753,000.$18,329,000. Sales through the domestic channels for the current quarter were $13,336,000,$14,127,000, an increase of 16.7%5.9% over the prior year. International shipments for the secondthird quarter of the current year were $4,993,000,$5,442,000, representing a 4.6% decrease9.0% increase from the previous year. The currentCurrent year’s third quarter decrease in international sales is primarily due to the $207,000 negativeinclude a $125,000 favorable impact due to foreign exchange rates.

Hardware sales in the current quarter were $7,782,000, an increase of 9.9%$8,356,000, a 6.2% improvement over the prior year’s third quarter hardware sales of $7,079,000. The$7,869,000. With the exception of T&M’s Recorder product line, the increase in hardware sales was evident in all three product groups. However, T&M’s other product line, Ruggedized printers & switches, posted a double-digit increment over the prior year’s third quarter sales of Ruggedized products. Quick Label’s hardware sales for the third quarter of the current quarter as compared toyear were up 9.2% over the prior year was primarily due to the demand for T&M’s new TMX line as well as the 20.3% increase in sales of the Ruggedized product line within T&M product group. Also contributing to the increase inyear’s sales. Grass Technologies’ current quarter sales was the 14.9% increase in sales of QuickLabel printers and the 19.2% increase in Grass Technologies’ clinical line of diagnostic systems, especially Long Term Epilepsy Monitoring Systems. The increase in the current quarter’s hardware sales was somewhat tempered by lower sales of T&M’s recorder and data acquisition product lines, as well as lower sales of Grass Technologies’ research line of products.increased 10.0% from prior year.

Consumables sales in the current quarter were $9,215,000,$9,873,000, representing an increase of 10.3%7.1% over the prior year’s third quarter consumable sales of $8,353,000.$9,215,000. The overall increase in consumable sales for the current quarter as compared to prior year’s third quarter was primarily dueattributable to sales inof digital color printer supplies within the QuickLabel product group, which were up 12.3%55.9%. Also contributing to the current quarter increase were the sales of Grass electrodes and cream products which increased 18.0%. This overall increase was slightly tempered by the decrease in sales of QuickLabel’s thermal transfer ribbon product lines as compared to prior year’s third quarter, sales. QuickLabel’s increased level of consumable salesdue to a decline in the current quarter is due to an increase in consumable demand from the Company’s installed base of printer customers, as well as label shipments from the Asheboro, North Carolina business, acquired in December 2009.thermal transfer printers.

-14-

Service and other revenues of $1,332,000$1,340,000 in the current quarter were up 8.6% fromincreased 7.6% compared to prior year’s third quarter service and other revenuerevenues of $1,226,000. The current quarter increase was shared among all three product groups with T&M up 6.2%, Quick Label up 13.7% and Grass Technology up 3.5% and was$1,245,000, primarily due to the increase in freightrepair and service revenue as well as parts and repair revenue which were up 13.1% and 9.8%, respectively, as compared to prior year’s thirdduring the quarter.

Current year

Gross profit for the third quarter gross profit was $7,401,000, reflecting an improvement over bothof the current year second quarter gross profit of $7,024,000 andwas $8,014,000, reflecting an 8.3% improvement over the prior year’s third quarter gross profit of $7,059,000, and is as a result of higher sales.$7,401,000. The Company’s gross profit margin of 40.4%41.0% in the current quarter reflects a decrease from thean increase as compared to prior year’s third quarter gross profit margin of 42.4%40.4%. The lowerincrease in gross profit margin for the current quarter as compared to prior year is primarily attributable to unfavorable salesfavorable product mix as well as higherand lower manufacturing costs due to unfavorable factory absorption.costs.

Operating expenses for the current quarter were $6,694,000,$6,826,000, a 9.8%2.0% increase from prior year’s third quarter operating expenses of $6,098,000.$6,694,000. Specifically, selling and marketing expenses for the current quarter increased 10.2%7.6% to $4,232,000$4,555,000 as compared to the previous year’s third quarter selling and marketing expenses of $3,840,000.$4,232,000. The increase in selling and marketing for the current quarter was primarily the result ofdue to increases in commissionspersonnel related costs, as well as an increase in rental and wagesleasing expenses due to personnel additionsthe expansion of both our German and increased sales. The increase in sales and marketing was also due to increased travel spending.Canadian facilities. General and administrative (G&A) expenses decreased 1.5%6.5% to $1,079,000$1,009,000 in the third quarter of the current year as compared to prior year’s third quarter G&A expenses of $1,095,000.$1,079,000. The decrease in G&A was primarily due to a decrease in banking and professional service feeswages, as compared to prior year. Spendingwell as a benefit recognized on the reversal of the sales based incentive earn out accrual which did not reach its negotiated sales goal. Investment in research & development (R&D) in the third quarter of the current year of $1,383,000$1,262,000 represents an 18.9% increase8.7% decrease compared to prior year’s third quarter spendinginvestment of $1,163,000$1,383,000. The decrease in R&D for the current quarter was primarily due to the increasedecline in outsourced development services fees.third party research and development. The current quarter spending in R&D represents 7.5%6.4% of sales, an increasea decline from the prior year’s third quarter level of 7.0%7.5%.

Third quarter operating income from operations is $707,000, a 26.4% decreaseof $1,188,000 increased 68.0% as compared to the prior year’s third quarter operating income of $961,000.$707,000. Operating margin for the third quarter of the current year of 3.9% is downwas 6.1% as compared to the prior year’s third quarter margin of 5.8%3.9%. The lowerincrease in both operating incomeprofit dollars and related margin for the current quarter is primarily attributable to unfavorable sales product mix; higher manufacturing cost due to unfavorable factory absorption;increased sales and increased selling and marketing and R&D expenses during the current quarter.favorable product mix.

Other incomeexpense during the third quarter was $24,000of the current year were $69,000 compared to $76,000other income of $24,000 in the third quarter of the previous year. The decrease for the current quarter was primarily due to lower investmentunfavorable foreign exchange.

The provision for federal and state income due to lower overall interest rates, as well as foreign exchange losses recognized intaxes for the second quarter of the current quarter due to the continuing strengtheningyear was $319,000 reflecting an effective tax rate of the US dollar as compared to the same period in the prior year.

In28.5%. The effective tax rate for the third quarter of the current year is a result of the Company recognized an income$113,000 tax benefit of $61,000, reflecting an effective tax rate of negative 8.4%. The current quarter tax benefit is due to the recognition of $251,000 related to the favorable resolution of a previously uncertain tax position and $150,000 related to the difference between the prior year’s tax provision and the actual returns as filed. This result compares to the prior year’s third quarter income tax expensebenefit of $353,000,$61,000 reflecting an effective tax rate of 34.1%negative 8.4%. The prior year’s third quarter tax benefit is due to the recognition of $251,000 related to the favorable resolution of a previously uncertain tax position and $150,000 related to difference between the prior year’s tax provision and the actual returns as filed.

The Company reported $792,000$800,000 in net income for the third quarter of the current year, reflecting a return on sales of 4.3%4.1% and generating EPS of $0.11 per diluted share. Included in net income is a tax benefit of $401,000,$113,000 or $0.05$0.02 per diluted share related to the favorable resolution of a previously uncertain tax position and favorable adjustment in the filing of the prior year’s tax returns. On a comparative basis, prior year’s third quarter recognized net income of $683,000,$792,000 reflecting a return on sales of 4.1%4.3% and an EPS of $0.09$0.11 per diluted share.

-15-

Nine Months Ended October 29, 2011 vs. Nine Months Ended October 30, 2010 vs. Nine Months Ended October 31, 2009

Net sales by product group and current quarter percentage change over prior year for the nine months ended October 30, 201029, 2011 and October 31, 200930, 2010 were: